The Los Angeles Post
U.S. World Business Lifestyle
Today: March 19, 2025
Today: March 19, 2025
Robin Respaut

Robin Respaut

Staff Writer

Latest From Robin Respaut

Health|Political|Science|US

Trump administration loophole snags US research grants from Lyme to lung disease

The Trump administration has for weeks been blocking the U.S.

Trump administration loophole snags US research grants from Lyme to lung disease
Health|Political|US

Some US health clinics grapple with federal funding squeeze

President Donald Trump's executive orders have begun to disrupt patient care in the United States, as some providers cannot access

Some US health clinics grapple with federal funding squeeze
Business|Europe|Health

Investors seek answers on Novo Nordisk's next-gen obesity drug CagriSema

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema amid a

Investors seek answers on Novo Nordisk's next-gen obesity drug CagriSema
Health|US

New York attorney general urges stronger safety warning on asthma drug Singulair

The attorney general for one of the most populous U.S. states this week urged federal drug regulators to address safety risks associated with the widely

New York attorney general urges stronger safety warning on  asthma drug Singulair
News|US

Weight-loss options for US youth are hard to come by

For many U.S. parents seeking help for a child with obesity, the most widely-endorsed treatment is out of reach - and it's not the popular weight-loss

Weight-loss options for US youth are hard to come by
News|US

Exclusive-US families begin to embrace weight-loss drugs for their children

A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's weight-loss drug Wegovy last year, a powerful new tool to

Exclusive-US families begin to embrace weight-loss drugs for their children

Follow